Phase 2 trial shows daridorexant boosts pediatric insomnia sleep time up to 50 minutes, including ADHD/ASD patients, with strong safety and phase 3 plans.
|Poll|January 9, 2014
Mini-quiz: Bipolar Disorder in Pediatric Cases
What is the natural course of bipolar disorder in pediatric cases? Take the quiz and learn more.
Advertisement
The natural course of bipolar disorder in pediatric cases tends to be . . .
Advertisement
Related to this article
Phase 2 data show RAP-219 eases acute bipolar mania with significant YMRS gains and encouraging tolerability, setting the stage for FDA talks and phase 3 plans.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Assessing Interventions for Insomnia in Peri- and Postmenopausal Women
2
October 2026 in Review: Updates on the Psychiatric Treatment Pipeline, FDA News
3
ALKS 7290 for Adjunctive Treatment for MDD Enters Phase 2 Study
4
GLP-1 Receptor Agonists May Reinforce Restriction in Patients With Eating Disorders
5